EUVIMEDEUVIMED entdecken
Crossref

Cost-benefit analysis of a tracking program for arteriovenous fistula maturation

Lingyan Meng iD, Jun Jie Ng iD, Rajesh Babu Dharmaraj, Raj Menon, Pei Ho iD

The Journal of Vascular Access · 2026

DOI: 10.1177/11297298261430544 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Vascular Access, 2026. Verfasst von Lingyan Meng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac, Thoracic and Vascular Surgery, National University Health System, Singapore. Hauptthemen laut MEDLINE: Arteriovenous Shunt, Surgical, Renal Dialysis, Health Care Costs. Die Arbeit nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Fail-to-mature (FTM) of arteriovenous fistula (AVF) imposes suffering onto hemodialysis patients and increases cost burden to the healthcare system. FTM may result from delayed maturation-assisting procedures, patients’ non-compliance or interdisciplinary miscommunication. A tracking program for AVF maturation was shown to improve clinical outcomes, however, extra manpower was required. This study aimed to evaluate the economic sustainability of the program.

Method

Data from two cohorts of patients (without tracking and with tracking) was collected retrospectively. A decision tree model was built to conduct a cost-benefit analysis comparing the cost pertaining to AVF maturation with and without the tracking program. The transitional probabilities in base case analysis were obtained from the study cohort. The costs of various procedures and manpower for tracking were extracted from official government websites. Sensitivity analysis were conducted to take account of uncertainties in parameters.

Results

In the study, 114 and 141 newly created AVFs from without-tracking and tracking group, respectively, were analyzed. The base-case study considered 21 possible scenarios (11 for pre-tracking and 10 for post-tracking). Manpower required for maturation tracking imposed a cost of S$33,644 per year. Without-tracking yields an expected AVF-related cost of S$7151, which was higher than that of the tracking group (S$6510). Assuming 120 AVFs created per year, the net monetary benefit obtained from the tracking program was estimated to be S$74,944 over 1 year. Sensitivity analysis suggested that the findings were robust for changes in both transitional probabilities and cost incurring events.

Conclusion

AVF maturation tracking program yields economic benefit to the healthcare system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arteriovenous Shunt, SurgicalRenal DialysisHealth Care CostsHumansCost-Benefit AnalysisRetrospective StudiesTreatment OutcomeTime FactorsDecision Support TechniquesDecision TreesModels, EconomicCost-Effectiveness AnalysisVascular PatencyProgram Evaluation

Stichwörter der Autor:innen

Arteriovenous fistulacare coordinationcost-benefit analysisfail-to-maturehemodialysis access

Autor:innen und Institutionen

  • Department of Cardiac, Thoracic and Vascular Surgery, National University Health System, Singapore.

ORCID-Profile: Lingyan Meng, Jun Jie Ng, Pei Ho

Zitieren

APA

Meng, L., Ng, J. J., Dharmaraj, R. B., Menon, R., & Ho, P. (2026). Cost-benefit analysis of a tracking program for arteriovenous fistula maturation. The Journal of Vascular Access. https://doi.org/10.1177/11297298261430544

Vancouver

Meng L, Ng JJ, Dharmaraj RB, Menon R, Ho P. Cost-benefit analysis of a tracking program for arteriovenous fistula maturation. The Journal of Vascular Access. 2026. doi:10.1177/11297298261430544

BibTeX
@article{Meng2026,
  author = {Meng, Lingyan and Ng, Jun Jie and Dharmaraj, Rajesh Babu and Menon, Raj and Ho, Pei},
  title = {Cost-benefit analysis of a tracking program for arteriovenous fistula maturation},
  journal = {The Journal of Vascular Access},
  year = {2026},
  doi = {10.1177/11297298261430544}
}
Kostenlos starten →